Soligenix, Inc. (SNGX) News
Filter SNGX News Items
SNGX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SNGX News Highlights
- SNGX's 30 day story count now stands at 3.
- Over the past 9 days, the trend for SNGX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DRUG, RARE and PAY are the most mentioned tickers in articles about SNGX.
Latest SNGX News From Around the Web
Below are the latest news stories about SOLIGENIX INC that investors may wish to consider to help them evaluate SNGX as an investment opportunity.
Here's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks FairKey Insights Soligenix will host its Annual General Meeting on 15th of December Total pay for CEO Christopher Schaber... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers on Friday morning! |
"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug DiscoverySoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that an article describing the potential use of HyBryte™ in the treatment of cutaneous T-cell lymphoma (CTCL) has been published in Frontiers in Drug Discovery. The mini-review summarizes findings about the use, mechanism and effectiveness of HyBryte™ in the treatment of CT |
Jefferies Is Pounding the Table on Snap (SNAP) StockSnap stock is heading higher on Thursday after the social media company's shares were upgraded to a 'buy' rating by Jefferies analysts. |
TSLA Stock Alert: The Tesla Cybertruck Launches TodayTesla stock is on the move Thursday as investors in TSLA shares prepare for the official Cybertruck launch event taking place today! |
Why Is Soligenix (SNGX) Stock Up 285% Today?Soligenix stock is rising higher on Thursday with heavy trading of SNGX shares after getting FDA approval for a Phase 2 clinical trial. |
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Behçet's DiseaseSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase 2a clinical trial entitled, "Pilot Study of SGX945 (Dusquetide) in the Treatment of Aphthous Ulcers in Behçet's Disease." The study is designed to evaluat |
SNGX: Filovirus Vaccine Candidates Demonstrate Two-Year Stability at Elevated Temperature…By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Filovirus Vaccine Candidates Demonstrate Two-Year Stability at Elevated Temperatures In September 2023, Soligenix, Inc. (NASDAQ:SNGX) announced that its thermostabilized bivalent and trivalent filovirus vaccine candidates demonstrated two-year stability at elevated temperatures (40ºC) while only needing |
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual MeetingSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its 2023 Annual Meeting of Stockholders (the "Annual Meeting"), which was reconvened on November 16, 2023, has been adjourned for the purpose of soliciting additional votes with respect to the proposals described in the Company's definitive proxy statement for the Annu |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday! |